Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies
Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes:
Ageism (bias against the elderly) is a real issue in the selection of patients to be included in clinical trials. A new study demonstrates how such bias may harm the elderly with renal cell carcinoma.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.